An Updated View of Translocator Protein (TSPO)

Classical and Novel TSPO Ligands for the Mitochondrial TSPO Can Modulate Nuclear Gene Expression: Implications for Mitochondrial Retrograde Signaling

(2017) Nasra Yasin et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs

(2016) Timothy C. Johnstone et al.   CHEMICAL REVIEWS

Highly selective luminescent nanostructures for mitochondrial imaging and targeting

(2016) E. Fanizza et al.   Nanoscale

Translocator Protein Ligand–PLGA Conjugated Nanoparticles for 5-Fluorouracil Delivery to Glioma Cancer Cells

(2014) Valentino Laquintana et al.   MOLECULAR PHARMACEUTICS

Nanopreparations for organelle-specific delivery in cancer

(2013) Swati Biswas et al.   ADVANCED DRUG DELIVERY REVIEWS

In vitro targeting and imaging the translocator protein TSPO 18-kDa through G(4)-PAMAM–FITC labeled dendrimer

(2013) Nunzio Denora et al.   JOURNAL OF CONTROLLED RELEASE

Novel codrugs with GABAergic activity for dopamine delivery in the brain

(2012) Nunzio Denora et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Translocator Protein (TSPO) Ligand−Ara-C (Cytarabine) Conjugates as a Strategy To Deliver Antineoplastic Drugs and To Enhance Drug Clinical Potential

(2010) Nunzio Denora et al.   MOLECULAR PHARMACEUTICS

Transport proteins (carriers) of mitochondria

(2008) Hartmut Wohlrab   IUBMB LIFE

Radiosynthesis and in vivo evaluation of N-[11C]methylated imidazopyridineacetamides as PET tracers for peripheral benzodiazepine receptors

(2008) Katsuhiko Sekimata et al.   NUCLEAR MEDICINE AND BIOLOGY